PATH
Menu

Late-stage trials of an advanced malaria vaccine candidate—which, if approved, would become the world’s first malaria vaccine—are under way. This article, published in Health Affairs, recounts the pivotal roles played by collaborations of nonprofit organizations, pharmaceutical companies, private and public donors, and countries whose citizens would benefit most directly from a vaccine.

Author(s): Loucq C, Birkett A, Poland D, Botting C, Nunes J, Ethelston S

Corporate author(s): PATH

Publication date: June 2011

Available materials

English

Producing a Successful Malaria Vaccine

(Located at content.healthaffairs.org)

Hard copies are not available.

Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.

Region: Africa

See also:

Vaccines and immunizationMalaria

Emerging and epidemic diseasesMalaria

For more information…

Contact: PATH Publications
Email: publications@path.org
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA